A nonclinical study refers to research conducted on non-human subjects to gather data on the safety and efficacy of a drug, medical device, or treatment before it is tested in humans. These studies are typically performed in laboratory settings using cell cultures, tissues, or animal models to assess potential risks and benefits.
Nonclinical studies are a crucial step in the drug development process, providing valuable information on pharmacology, toxicology, and pharmacokinetics. They help researchers determine appropriate dosing, identify potential side effects, and establish a foundation for subsequent clinical trials involving human participants.
The term 'nonclinical study’ is crucial in clinical research as it represents a critical phase in drug development that precedes human trials. It provides essential safety and efficacy data that informs decisions on whether to proceed with clinical studies, helping to protect human subjects from unnecessary risks.
Understanding nonclinical studies is important for researchers, regulators, and sponsors involved in clinical trials. It aids in designing appropriate clinical protocols, interpreting results, and making informed decisions about drug candidates, ultimately contributing to the development of safer and more effective treatments.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant